軒竹生物是國(guó)內(nèi)大型醫(yī)藥集團(tuán)四環(huán)醫(yī)藥（0460.HK）的創(chuàng)新藥研究院。匯聚了由海歸科學(xué)家?guī)ьI(lǐng)的400余人研發(fā)團(tuán)隊(duì)，聚焦腫瘤、代謝、消化等前沿領(lǐng)域，致力于1.1類新藥的開發(fā)。是國(guó)內(nèi)少數(shù)同時(shí)具備小分子化藥、大分子生物藥開發(fā)及產(chǎn)業(yè)化、商業(yè)化能力的高新生物醫(yī)藥科技企業(yè)。
?
XuanZhu BioPharma is an original new drug research institute of Sihuan Pharmaceutical(0460.HK),a large domestic pharmaceutical group. The company has converged research and development team with more than 400 people led by oversea scientists.? The company is focusing on oncology, metabolism, digestion and other frontier fields, committed to the development of 1.1 type of new drugs. The company is one of few domestic high-tech biomedical technology enterprises consisted with development, industrialization and commercialization capabilities of small molecule drugs and macromolecules.